Brand Manager, Prevenar /Gobik Marketing

Prevenar/Gobik/Ticovac marketing team, Vaccine Commercial Strategy, Primary Care, handles 3 products with 4 indications: Prevenar 20 for adult, Prevenar 20 for pediatric, Gobik, and Ticovac. All vaccines and indications were launched in 2024, and the marketing team's mission is to deliver these products to as many people as possible and put them on a growth trajectory. The primary role of the Prevenar / Gobik Brand Manager is to focus efforts on maximizing the adult indications for Prevenar 20. Prevenar 20 Adult faces intense competition with the entry of a competitor in October 2025. However, Prevenar 20 Adult is expected to be introduced into the National Immunization Program (NIP) in 2026. Our team will leverage this NIP inclusion to maximize market share and vaccination rates. In this dynamic environment, Prevenar/Gobik Brand Manager has commercial responsibility of Prevenar 20 Adult including strategy development based on strong market understanding and customer insights, annual tactics planning & roll out etc. This position also covers all brand marketing related to pediatric indications for Prevenar 20 and Gobik. In particular, smooth co-promotion relationship with Tanabe Pharme is required for Gobik. The role will closely work with Prevenar/Gobik/Ticovac Sr. Brand Manager as well as customer facing members to maximize the value of Prevenar 20 Adult/Pediatric and Gobik in Japan. In addition, this role requires cross-functional leadership among multiple internal functions.